| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 839 | 2021 |
| Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021 LT Brandal, E MacDonald, L Veneti, T Ravlo, H Lange, U Naseer, ... Eurosurveillance 26 (50), 2101147, 2021 | 388 | 2021 |
| Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, ... Proceedings of the National Academy of Sciences 117 (40), 25018-25025, 2020 | 361 | 2020 |
| Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure T Ueland, JC Holter, AR Holten, KE Müller, A Lind, GK Bekken, S Dudman, ... The Journal of infection 81 (3), e41, 2020 | 172 | 2020 |
| Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement H Hoel, L Heggelund, DH Reikvam, B Stiksrud, T Ueland, AE Michelsen, ... Journal of internal medicine 289 (4), 523-531, 2021 | 106 | 2021 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 91* | 2022 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 91 | 2021 |
| Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19 M Jøntvedt Jørgensen, JC Holter, EE Christensen, C Schjalm, K Tonby, ... Scientific reports 10 (1), 21697, 2020 | 85 | 2020 |
| An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses FO Pettersen, EA Torheim, AEA Dahm, IS Aaberge, A Lind, M Holm, ... Journal of virology 85 (13), 6557-6566, 2011 | 81 | 2011 |
| Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium … LF Reyes, S Murthy, E Garcia-Gallo, M Irvine, L Merson, I Martin-Loeches, ... ERJ open research 8 (1), 2022 | 60 | 2022 |
| Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study A Søraas, KT Kalleberg, JA Dahl, CL Søraas, TÅ Myklebust, E Axelsen, ... PloS one 16 (8), e0256142, 2021 | 55 | 2021 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 50 | 2023 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 49 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 40 | 2021 |
| Elevated plasma sTIM-3 levels in patients with severe COVID-19 T Ueland, L Heggelund, A Lind, AR Holten, K Tonby, AE Michelsen, ... Journal of Allergy and Clinical Immunology 147 (1), 92-98, 2021 | 38 | 2021 |
| Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial K Brekke, A Lind, C Holm-Hansen, IL Haugen, B Sørensen, M Sommerfelt, ... PloS one 9 (11), e112556, 2014 | 38 | 2014 |
| Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory A Lind, R Barlinn, ET Landaas, LL Andresen, K Jakobsen, C Fladeby, ... Journal of Clinical Virology 141, 104906, 2021 | 32 | 2021 |
| Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation M Trøseid, A Lind, P Nowak, B Barqasho, B Heger, I Lygren, KK Pedersen, ... Innate immunity 19 (3), 290-297, 2013 | 31 | 2013 |
| The incidence of infectious diseases and viruses other than SARS-CoV-2 amongst hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020–2021 PK Knudsen, A Lind, I Klundby, S Dudman Journal of Clinical Virology Plus 2 (1), 100060, 2022 | 30 | 2022 |
| Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes AMB Kran, TØ Jonassen, M Sannes, K Jakobsen, A Lind, A Mæland, ... Journal of clinical microbiology 47 (7), 2170-2174, 2009 | 30 | 2009 |
